{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:10:59Z","timestamp":1792188659750,"version":"4.4.0"},"reference-count":36,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T00:00:00Z","timestamp":1739664000000},"content-version":"unspecified","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","award":["AN 687\/9-1"],"award-info":[{"award-number":["AN 687\/9-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","award":["SCHI 1497\/2-1"],"award-info":[{"award-number":["SCHI 1497\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,1,14]]},"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Glaucoma is one of the most common causes of blindness and affects more than 70\u2009million people worldwide. The disease is characterised by the loss of retinal ganglion cells associated with a progressive optic neuropathy, resulting in an impairment of visual functions, for example, visual field loss. Nowadays, the only modifiable risk factor is the increase in intraocular pressure, and its treatment is to lower this pressure by medication, laser treatment or surgery to avoid disease progression. New methods for preventing and reversing vision loss are thus urgently needed. Several small and two multicentre studies have presented evidence that repetitive transorbital alternating current stimulation (rtACS) can lead to long-lasting visual field improvement. This could open a new and inexpensive therapeutic option for optic atrophy. However, the level of evidence for this method is still fairly rather poor, and further trials are needed. Therefore, this clinical trial aims to prove the effectiveness of rtACS compared with sham stimulation in patients with primary open-angle glaucoma (POAG).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>VIRON (Vision Restoration in Optic Neuropathy) is a national, multicentre, prospective, randomised, placebo-controlled, double-blind trial with three arms. The primary objective is to assess the effectiveness of rtACS in patients with POAG compared with sham stimulation. The primary outcome is the change in mean defect (MD) in the visual field immediately after 10 sessions of rtACS (days 9, 16 and 23) compared with the values of initial perimetry (days \u221221 to \u201314 and 0) after applying electrical stimulation with a classical montage, compared with sham and electrical stimulation using individualised montage. Secondary outcome measures comprise a long-term effect with changes in MD at 24 weeks after stimulation, and data from the National Eye Institute Visual Function-25 and quality of life (Short Form 36) questionnaires. The target population are patients with glaucomatous optic atrophy and significant glaucomatous visual field defects (MD of 5\u201322\u2009dB) due to POAG.<\/jats:p>\n                    <jats:p>After randomisation, patients received either classical rtACS (group 1), individual rtACS (group 2) or sham stimulation (group 3) in daily 25\u2009min stimulation sessions in two series of five consecutive days separated by a weekend interval. In group 1, active stimulation will be via the routinely applied montage using two electrodes affixed on the right and left side of the head, next to the eyes, with straightforward fixation. In group 2, the current flow will be individually modelled (MRI-based) to target areas of partial visual field defects by optimising electrode positions in conjunction with an optimised visual fixation direction. Group 3 with sham stimulation will serve as control.<\/jats:p>\n                    <jats:p>The calculated sample size required to achieve a statistical power of 80% for a relevant effect size and allow for dropouts was 300 (100 per group). The trial has already begun with the first patient in July 2023. The planned recruitment period is 24 months with an estimated end of the study in November 2025 (last patient out). An adjusted extension of the study period is planned.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>VIRON was approved by the Central Ethics Committee of the University Medical Center G\u00f6ttingen (19 October 2022) and those of the individual participating centres (Bonn: 446\/23-EP, Hamburg: 2023-200889-BO-bet, Cologne: 23-1487 and Mainz: 2023-17399-\u00a723b). The study protocol complies with the Declaration of Helsinki, the national medicine device regulation (MDR) laws and the international standards of good clinical practice (GCP).<\/jats:p>\n                    <jats:p>\n                      The study protocol (V.5, 24 November 2023) was designed following the Standard Protocol Items: Recommendations for Interventional Trials guidelines and is registered on\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/drks.de\/search\/de\/trial\/DRKS00029129\">https:\/\/drks.de\/search\/de\/trial\/DRKS00029129<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                    <jats:p>As study initiatior the University Medical Center G\u00f6ttingen (UMG) is responsible for data ownership and data management of the VIRON study. The study data will be published within 6\u2009months of the study being completed. After the publication of the primary results, all data are anonymised and published in an open-access journal to ensure access to the data for third parties.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/drks.de\/search\/de\/trial\/DRKS00029129\">https:\/\/drks.de\/search\/de\/trial\/DRKS00029129<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-091705","type":"journal-article","created":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T06:11:19Z","timestamp":1739686279000},"page":"e091705","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Vision Restoration through transorbital electrical stimulation in Optic Neuropathy in patients with significant optic atrophy due to primary open-angle glaucoma\u2014a randomised, controlled, double-blind, multicentre clinical trial: the VIRON study protocol"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6504-9532","authenticated-orcid":false,"given":"Michael","family":"Schittkowski","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, University Medical Center Goettingen, Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Pohlner","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Medical Center Goettingen, Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Mercieca","sequence":"additional","affiliation":[{"name":"Ophthalmology, University Hospital Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Grohmann","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Medical Center Hamburg, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Kr\u00f6ger","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Medical Center Hamburg, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Prokosch","sequence":"additional","affiliation":[{"name":"Ophthalmology, University Hospital Cologne, Koeln, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Lorenz","sequence":"additional","affiliation":[{"name":"Ophthalmology, Johannes Gutenberg University Hospital Mainz, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Beck","sequence":"additional","affiliation":[{"name":"Ophthalmology, Johannes Gutenberg University Hospital Mainz, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Haueisen","sequence":"additional","affiliation":[{"name":"Technische Universit\u00e4t Ilmenau, Ilmenau, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Hunold","sequence":"additional","affiliation":[{"name":"Technische Universit\u00e4t Ilmenau, Ilmenau, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bernhard","sequence":"additional","affiliation":[{"name":"Technische Universit\u00e4t Ilmenau, Ilmenau, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Radbruch","sequence":"additional","affiliation":[{"name":"Neuroradiology, University Hospital Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Dechent","sequence":"additional","affiliation":[{"name":"Cognitive Neurology, University Medical Center Goettingen, Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Brockmann","sequence":"additional","affiliation":[{"name":"Neuroradiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Hoerauf","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Medical Center Goettingen, Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"B\u00e4hr","sequence":"additional","affiliation":[{"name":"Neurology, University of Goettingen Faculty of Medicine, Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7767-114X","authenticated-orcid":false,"given":"Bettina","family":"Wabbels","sequence":"additional","affiliation":[{"name":"Ophthalmology, University Hospital Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Enders","sequence":"additional","affiliation":[{"name":"Ophthalmology, University Hospital Cologne, Koeln, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Asendorf","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, University Medical Center Goettingen, Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"van Oterendorp","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Medical Center Goettingen, Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Antal","sequence":"additional","affiliation":[{"name":"Neurology, University of Goettingen Faculty of Medicine, Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,2,16]]},"reference":[{"key":"2025121509323242000_15.2.e091705.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.3192"},{"key":"2025121509323242000_15.2.e091705.2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/eye.2015.244","article-title":"A view on glaucoma--are we seeing it clearly?","volume":"30","author":"Crabb","year":"2016","journal-title":"Eye (Lond)"},{"key":"2025121509323242000_15.2.e091705.3","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.643685","article-title":"Transneuronal Degeneration in the Brain During Glaucoma","volume":"13","author":"You","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"2025121509323242000_15.2.e091705.4","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8397521","article-title":"Therapeutic Strategies for Attenuation of Retinal Ganglion Cell Injury in Optic Neuropathies: Concepts in Translational Research and Therapeutic Implications","volume":"2019","author":"Fu","year":"2019","journal-title":"Biomed Res Int"},{"key":"2025121509323242000_15.2.e091705.5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1167\/iovs.16-19906","article-title":"Transcorneal Electrical Stimulation for Patients With Retinitis Pigmentosa: A Prospective, Randomized, Sham-Controlled Follow-up Study Over 1 Year","volume":"58","author":"Schatz","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2025121509323242000_15.2.e091705.6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40123-013-0012-5","article-title":"Transcorneal electrical stimulation in patients with retinal artery occlusion: a prospective, randomized, sham-controlled pilot study","volume":"2","author":"Naycheva","year":"2013","journal-title":"Ophthalmol Ther"},{"key":"2025121509323242000_15.2.e091705.7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.brs.2011.07.007","article-title":"Restoration of vision after optic nerve lesions with noninvasive transorbital alternating current stimulation: a clinical observational study","volume":"4","author":"Fedorov","year":"2011","journal-title":"Brain Stimul"},{"key":"2025121509323242000_15.2.e091705.8","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2013.00584","article-title":"Remaining visual field and preserved subjective visual functioning prevent mental distress in patients with visual field defects","volume":"7","author":"Gall","year":"2013","journal-title":"Front Hum Neurosci"},{"key":"2025121509323242000_15.2.e091705.9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.brs.2011.07.003","article-title":"Noninvasive transorbital alternating current stimulation improves subjective visual functioning and vision-related quality of life in optic neuropathy","volume":"4","author":"Gall","year":"2011","journal-title":"Brain Stimul"},{"key":"2025121509323242000_15.2.e091705.10","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.neuropsychologia.2013.06.028","article-title":"Evaluation of two treatment outcome prediction models for restoration of visual fields in patients with postchiasmatic visual pathway lesions","volume":"51","author":"Gall","year":"2013","journal-title":"Neuropsychologia"},{"key":"2025121509323242000_15.2.e091705.11","first-page":"493","article-title":"Non-invasive alternating current stimulation improves vision in optic neuropathy","volume":"29","author":"Sabel","year":"2011","journal-title":"Restor Neurol Neurosci"},{"key":"2025121509323242000_15.2.e091705.12","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-53355-5.00013-0"},{"key":"2025121509323242000_15.2.e091705.13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.brs.2012.03.008","article-title":"Progressive enhancement of alpha activity and visual function in patients with optic neuropathy: a two-week repeated session alternating current stimulation study","volume":"6","author":"Schmidt","year":"2013","journal-title":"Brain Stimul"},{"key":"2025121509323242000_15.2.e091705.14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156134","article-title":"Alternating Current Stimulation for Vision Restoration after Optic Nerve Damage: A Randomized Clinical Trial","volume":"11","author":"Gall","year":"2016","journal-title":"PLoS One"},{"key":"2025121509323242000_15.2.e091705.15","unstructured":"DOG . Transorbitale-Wechselstromstimulatio bei Optikusatrophie. 2016."},{"key":"2025121509323242000_15.2.e091705.16","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-3-201302050-00583"},{"key":"2025121509323242000_15.2.e091705.17","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1109\/TNSRE.2021.3120148","article-title":"Evaluating Current Density Modeling of Non-Invasive Eye and Brain Electrical Stimulation Using Phosphene Thresholds","volume":"29","author":"Sabel","year":"2021","journal-title":"IEEE Trans Neural Syst Rehabil Eng"},{"key":"2025121509323242000_15.2.e091705.18","doi-asserted-by":"publisher","DOI":"10.1007\/s00347-013-2813-2"},{"key":"2025121509323242000_15.2.e091705.19","doi-asserted-by":"crossref","unstructured":"Puonti O , Van Leemput K , Saturnino GB , et al . Accurate and robust whole-head segmentation from magnetic resonance images for individualized head modeling. Neuroimage 2020;219. doi:10.1016\/j.neuroimage.2020.117044","DOI":"10.1016\/j.neuroimage.2020.117044"},{"key":"2025121509323242000_15.2.e091705.20","doi-asserted-by":"publisher","DOI":"10.1088\/0031-9155\/41\/11\/003"},{"key":"2025121509323242000_15.2.e091705.21","doi-asserted-by":"publisher","DOI":"10.1007\/BF02474537"},{"key":"2025121509323242000_15.2.e091705.22","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1088\/0031-9155\/46\/11\/319","article-title":"A model of the electrical volume conductor in the region of the eye in the ELF range","volume":"46","author":"Lindenblatt","year":"2001","journal-title":"Phys Med Biol"},{"key":"2025121509323242000_15.2.e091705.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2015.01.033"},{"key":"2025121509323242000_15.2.e091705.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.apnum.2009.02.006"},{"key":"2025121509323242000_15.2.e091705.25","doi-asserted-by":"crossref","unstructured":"Saturnino GB , Madsen KH , Thielscher A . Optimizing the electric field strength in multiple targets for multichannel transcranial electric stimulation. J Neural Eng 2021;18. doi:10.1088\/1741-2552\/abca15","DOI":"10.1088\/1741-2552\/abca15"},{"key":"2025121509323242000_15.2.e091705.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1991.tb03623.x"},{"key":"2025121509323242000_15.2.e091705.27","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.116.11.1496"},{"key":"2025121509323242000_15.2.e091705.28","doi-asserted-by":"publisher","DOI":"10.1002\/bimj.200810425"},{"key":"2025121509323242000_15.2.e091705.29","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2007.135012"},{"key":"2025121509323242000_15.2.e091705.30","doi-asserted-by":"publisher","DOI":"10.1002\/pst.398"},{"key":"2025121509323242000_15.2.e091705.31","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/IJG.0000000000000710","article-title":"Measuring Rates of Visual Field Progression in Linear Versus Nonlinear Scales: Implications for Understanding the Relationship Between Baseline Damage and Target Rates of Glaucoma Progression","volume":"26","author":"Liebmann","year":"2017","journal-title":"J Glaucoma"},{"key":"2025121509323242000_15.2.e091705.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2017.06.001"},{"key":"2025121509323242000_15.2.e091705.33","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-2457(03)00235-9"},{"key":"2025121509323242000_15.2.e091705.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2007.01.004"},{"key":"2025121509323242000_15.2.e091705.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2019.02.011"},{"key":"2025121509323242000_15.2.e091705.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2019.116183"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-091705","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T17:32:42Z","timestamp":1765819962000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-091705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,16]]},"published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1136\/bmjopen-2024-091705"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-091705","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}